Progenie molecular performs the coronavirus SARS-CoV-2 (COVID-19) detection tests using real-time PCR.
The coronavirus SARS-CoV-2 detection tests must be performed following the recommendations of the health authorities and it is mandatory to have a medical prescription.
- Prevention plan
- Infection contingency plan
- Maintenance of healthcare activity
- Early diagnosis in elderly patients
- Classification of residents according to clinical data
- Maintenance of public services (police, etc.)
- Surveillance of the health of public employees
- Minimize the impact of the health crisis on society
- Avoidance of sick leave
- Anticipate possible management responsibilities
- Prevention plan and health surveillance
- Healthcare of workers and clients
- Avoidance of sick leave
- Continuity of business activity
- Anticipation of possible business responsibilities
- Diagnostic tests included in the care process
- Pre-operative tests
- Safe delivery assistance
- Health surveillance of health workers
- Continuity of healthcare activity
We provide the material for taking samples (swabs), and we take care of their collection in special containers.
Clinical samples are delivered in less than 24 hours from any national destination (except islands). As soon as the samples are delivered, our laboratory confirms their condition is of standard, as well as the requested tests and other pre-analytical data.
Results are delivered within 24 hours. The reports are available in a private area of our servers. Our system will notify you that you can access your reports in an absolutely confidential manner. However, if you prefer, we will send them to you by password-protected email.
We make adjusted budgets based on the number of samples, with the aim that coronavirus detection tests are within the reach of the majority of people, companies, public organizations, hospitals and laboratories.
The elderly are those who suffer from the most serious forms of the disease and those who carry the greatest risk to life. They usually present particular symptoms, such as general malaise, low-grade fever, weakness, anorexia, gastrointestinal disorders and worsening of their cognitive state, compared to the typical symptoms of younger patients: fever, dry cough and myalgia.
Part of a greater predisposition to manifest the disease, older people usually present other chronic diseases that worsen the prognosis of coronavirus infection. Due to this differential symptomatology, caregivers must pay attention to these minimal changes, with the aim of carrying out a early diagnostic.
Nursing homes are the places most affected by the health crisis generated by this coronavirus. In these establishments, older people share spaces and equipment. They are cared for by staff who are in continuous contact with many of them, and can inadvertently act as a vector of transmission. It is important to have action protocols that prevent infection within establishments as much as possible.
Apart from preventive measures, all nursing homes should have a contingency plan for this disease, established with medical criteria and in accordance with health authorities. This must take into account aspects such as the classification and location of residents, the treatment of the sick, the management of asymptomatic carriers, both residents and employees, the correct use of personal protective equipment (PPE), etc.
Carrying out tests on both residents and workers allows us to establish a "baseline snapshot" of the situation in the nursing home, and from there make individualized decisions for each resident or worker. Subsequently, periodic tests must be carried out, aimed at exposed staff and residents.
Some of the individuals with negative results in the first tests may test positive in subsequent tests and vice versa. This is due to the existence of window periods, the dynamics of the infection (still unknown) and the variability involved in taking the sample. Cases of consecutive positive and negative results have also been described, which show the difficulty in diagnosing this infection, and the need to perform tests on an ongoing basis.
The European Agency for Safety and Health at Work (EU-OSHA) has recently published recommendations to ensure the health and safety of workers when they return to the workplace as a result of the SARS-CoV-2 health crisis. (COVID-19). The aim is to minimize exposure to coronavirus in the work environment, update risk assessment, help manage workers who have been ill and provide practical advice to staff. Ensuring that workers can return to the workplace in a safe and healthy environment is considered a priority.
Taking care of the health of their workers is an obligation of all companies, as stated in the Spanish legal system. Health surveillance is a key element for the well-being of workers and their families. On the contrary, when diseases spread in the work environment, they can generate great personal, family and collective suffering. From a business point of view, it is essential to have a healthy workforce for the proper functioning of the organization. Illnesses and sick leave that they entail can compromise the future of the company.
SARS-CoV-2 infection can cause a disease whose clinical course can vary from a life-threatening pathology to asymptomatic forms. Intermediate forms usually involve sick leave lasting several weeks. Given the high infectivity of this virus, it is advisable to carry out periodic screening of the workforce, and especially before incorporation after a sick leave or a prolonged period of rest. In this way, we can try to guarantee the health of workers and their families, prevent infections by asymptomatic personnel, and achieve continuity of work activity.
It is undeniable that workers face a risk of infection when returning to their workplace, just as a customer does when coming into contact with an infected worker. The fundamental question is to determine what responsibility the company holds in these cases.